Crit Care Nurse 2019 Aug;39(4):e1-e7
Julia McSweeney, Emily Rosenholm, and Katherine Penny are nurse practitioners, Cardiology Program, Boston Children's Hospital, Boston, Massachusetts. Mary P. Mullen is Associate Director, Pediatric Pulmonary Hypertension Program, Boston Children's Hospital, and Assistant Professor of Pediatrics, Harvard Medical School, Boston. Thomas J. Kulik is Director, Pediatric Pulmonary Hypertension Program, Boston Children's Hospital, and Assistant Professor of Pediatrics, Harvard Medical School.
Background: Pulmonary hypertension is a rare, life-threatening disease with limited therapeutic options and no definitive cure. Continuous intravenous prostacyclin therapy is indicated for treatment of severe disease. These medications have a narrow therapeutic index and a brief half-life; therefore, administration errors can be lethal. Read More